Researchers at Texas Biomed collaborate with teams at UC Santa Cruz and Brigham Young University to verify the new diagnostic system, which combines optofluidics and nanopores, accurately tests for COVID-19 and Zika virus.
Researchers at Texas Biomed collaborate with teams at UC Santa Cruz and Brigham Young University to verify the new diagnostic system, which combines optofluidics and nanopores, accurately tests for COVID-19 and Zika virus.
Designed by doctors. Powered by AI.
Owned by you.